FINWIRES · TerminalLIVE
FINWIRES

Duolingo Yet to See User Turnaround Despite Growth Push, Morgan Stanley Says

By

Duolingo's (DUOL) focus on free user growth has strengthened retention, while daily active users have yet to turn meaningfully higher, Morgan Stanley said Tuesday in a report.

The company kept its fiscal 2026 bookings outlook unchanged even after a Q1 beat. Management remains focused on the long term and views the 2026 reset as a chance to reaccelerate user growth, the report said.

Morgan Stanley raised revenue estimates by 1% in 2026 and 2% in 2027 on stronger advertising trends.

Duolingo is developing a range of products, including expanded content production, revamped Asian-language courses, speaking modules, tutors, and longer free trials, which could support user growth and strengthen revenue over time, the report said.

Morgan Stanley cut its price target on Duolingo stock to $95 from $100 and reiterated its equal-weight rating.

Price: $103.34, Change: $-6.90, Percent Change: -6.26%

Related Articles

Wire

IAC Q1 Loss Narrows, Revenue Falls; Shares Drop After Hours

IAC (IAC) reported a Q1 loss late Monday of $0.94 per diluted share, narrowing from the loss of $2.64 a year earlier.Analysts polled by FactSet expected a loss of $0.37.Revenue in the three months ended March 31 fell to $422.9 million from $481.7 million a year earlier.Analysts surveyed by FactSet expected $520.3 million.IAC shares fell 8.6% in after-hours trading.

$IAC
Wire

Vornado Realty Trust Q1 Non-GAAP FFO, Revenue Fall; Shares Drop After Hours

Vornado Realty Trust (VNO) reported Q1 non-GAAP funds from operations late Monday of $0.52 per diluted share, down from $0.63 a year earlier.Analysts polled by FactSet expected $0.51.Revenue in the three months ended March 31 fell to $459.1 million from $461.6 million a year earlier.Analysts surveyed by FactSet expected $431.7 million.Vornado shares fell 3% in after-hours trading.

$VNO
Wire

GeneDx Q1 Swings to Adjusted Loss, Revenue Rises; 2026 Revenue Guidance Lowered; Shares Fall

GeneDx (WGS) reported Monday Q1 adjusted loss of $0.28 per diluted share, swinging from an adjusted earnings of $0.31 a year earlier.Analysts polled by FactSet expected loss of $0.02.Revenue for the quarter ended March 31 was $102.3 million, up from $87.1 million a year earlier.Analysts surveyed by FactSet expected $112.5 million.For Q2, the company expects revenue of $110 million to $112 million. Analysts expect $130.3 million.The company now expects 2026 revenue of $475 million to $490 million, down from $540 million to $555 million expected earlier. Analysts expect $550.0 million.Shares of the company were down over 45% during after-hours activity.

$WGS